• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

社区获得性或医疗保健相关性细菌感染会增加肝硬化急性失代偿患者的长期死亡率。

Community- or Healthcare-Associated Bacterial Infections Increase Long-Term Mortality in Patients With Acute Decompensation of Cirrhosis.

作者信息

Zhao Hong, Shi Yu, Dong Huihui, Hu Jianhua, Zhang Xuan, Yang Meifang, Fan Jun, Ma Weihang, Sheng Jifang, Li Lanjuan

机构信息

State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Disease, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China.

State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Disease, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China.

出版信息

Am J Med Sci. 2018 Feb;355(2):132-139. doi: 10.1016/j.amjms.2017.08.003. Epub 2017 Aug 3.

DOI:10.1016/j.amjms.2017.08.003
PMID:29406040
Abstract

BACKGROUND

The aim of the present study was to determine the specific role of different types of bacterial infections (BIs) on the prognosis of cirrhotic patients with acute decompensation (AD).

METHODS

We performed a prospective, observational cohort study consisting of 492 cirrhotic patients with AD at our center from February 2014 to March 2015. Clinical, laboratory and survival data were collected. The relationship between BIs and mortality was analyzed.

RESULTS

BIs were identified in 157 of 492 patients at the time of admission or during the hospital stay. Among the patients, 65 had community-acquired (CA) or healthcare-associated (HCA) BIs, 54 developed hospital-acquired (HA) BIs, and 38 had CA/HCA with HA BIs. Patients with CA/HCA BIs had higher 90-day, 1-year and 2-year mortality rates (29.2%, 44.6% and 52.3%, respectively) and CA/HCA BIs remained an independent risk factor for long-term mortality on multivariate analysis (1 year: hazard ratio = 1.60; 95% CI: 1.07-2.41; P = 0.023 and 2 year: hazard ratio = 1.54; 95% CI: 1.05-2.25; P = 0.026). In contrast, patients with HA BIs had a higher 28-day mortality rate than patients with CA/HCA BIs. Logistic regression analysis showed previous ascites and prior BIs within 3 months were independent risk factors for CA/HCA BIs, whereas invasive minor surgical procedures with acute-on-chronic liver failure throughout the hospital stay and high chronic liver failure-sequential organ failure assessment scores were associated with nosocomial BIs.

CONCLUSIONS

CA/HCA BIs were associated with increased long-term mortality in cirrhotic patients with AD, whereas nosocomial BIs may be related to poor short-term prognosis.

摘要

背景

本研究的目的是确定不同类型的细菌感染(BI)对急性失代偿期(AD)肝硬化患者预后的具体作用。

方法

我们进行了一项前瞻性观察队列研究,纳入了2014年2月至2015年3月在我们中心就诊的492例AD肝硬化患者。收集了临床、实验室和生存数据。分析了BI与死亡率之间的关系。

结果

492例患者中,157例在入院时或住院期间被确诊为BI。其中,65例为社区获得性(CA)或医疗保健相关(HCA)BI,54例发生医院获得性(HA)BI,38例既有CA/HCA BI又有HA BI。CA/HCA BI患者的90天、1年和2年死亡率较高(分别为29.2%、44.6%和52.3%),多因素分析显示CA/HCA BI仍然是长期死亡率的独立危险因素(1年:风险比=1.60;95%可信区间:1.07-2.41;P=0.023;2年:风险比=1.54;95%可信区间:1.05-2.25;P=0.026)。相比之下,HA BI患者的28天死亡率高于CA/HCA BI患者。逻辑回归分析显示,既往腹水和3个月内的既往BI是CA/HCA BI的独立危险因素,而住院期间的侵入性小手术合并慢加急性肝衰竭以及高慢性肝衰竭-序贯器官衰竭评估评分与医院获得性BI相关。

结论

CA/HCA BI与AD肝硬化患者的长期死亡率增加相关,而医院获得性BI可能与短期预后不良有关。

相似文献

1
Community- or Healthcare-Associated Bacterial Infections Increase Long-Term Mortality in Patients With Acute Decompensation of Cirrhosis.社区获得性或医疗保健相关性细菌感染会增加肝硬化急性失代偿患者的长期死亡率。
Am J Med Sci. 2018 Feb;355(2):132-139. doi: 10.1016/j.amjms.2017.08.003. Epub 2017 Aug 3.
2
Healthcare-associated and nosocomial bacterial infections in cirrhosis: predictors and impact on outcome.肝硬化患者的医疗保健相关和医院内细菌感染:预测因素及对预后的影响
Liver Int. 2015 Feb;35(2):391-400. doi: 10.1111/liv.12625. Epub 2014 Jul 21.
3
Second infections independently increase mortality in hospitalized patients with cirrhosis: the North American consortium for the study of end-stage liver disease (NACSELD) experience.二次感染独立增加肝硬化住院患者的死亡率:北美终末期肝病研究协会(NACSELD)的经验。
Hepatology. 2012 Dec;56(6):2328-35. doi: 10.1002/hep.25947.
4
A multicenter prospective study of infections related morbidity and mortality in cirrhosis of liver.一项关于肝硬化感染相关发病率和死亡率的多中心前瞻性研究。
Indian J Gastroenterol. 2014 Jul;33(4):336-42. doi: 10.1007/s12664-014-0461-3. Epub 2014 Jun 1.
5
Predictors of mortality among patients with compensated and decompensated liver cirrhosis: the role of bacterial infections and infection-related acute-on-chronic liver failure.代偿期和失代偿期肝硬化患者的死亡预测因素:细菌感染及感染相关慢加急性肝衰竭的作用
Scand J Gastroenterol. 2015 Jul;50(7):875-83. doi: 10.3109/00365521.2015.1017834. Epub 2015 Feb 19.
6
Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis.急性慢性肝衰竭是一种独特的综合征,发生在肝硬化急性失代偿的患者中。
Gastroenterology. 2013 Jun;144(7):1426-37, 1437.e1-9. doi: 10.1053/j.gastro.2013.02.042. Epub 2013 Mar 6.
7
Bacterial infection in compensated viral cirrhosis impairs 5-year survival (ANRS CO12 CirVir prospective cohort).代偿期病毒性肝硬化的细菌感染会降低 5 年生存率(ANRS CO12 CirVir 前瞻性队列研究)。
Gut. 2017 Feb;66(2):330-341. doi: 10.1136/gutjnl-2015-310275. Epub 2015 Oct 28.
8
Characteristics, risk factors, and mortality of cirrhotic patients hospitalized for hepatic encephalopathy with and without acute-on-chronic liver failure (ACLF).肝硬化患者因肝性脑病住院的特征、风险因素和死亡率,伴有和不伴有慢加急性肝衰竭(ACLF)。
J Hepatol. 2014 Feb;60(2):275-81. doi: 10.1016/j.jhep.2013.10.004. Epub 2013 Oct 12.
9
Single-centre validation of the EASL-CLIF consortium definition of acute-on-chronic liver failure and CLIF-SOFA for prediction of mortality in cirrhosis.单中心验证 EASL-CLIF 联盟定义的慢加急性肝衰竭和 CLIF-SOFA 对肝硬化患者死亡率的预测价值。
Liver Int. 2015 May;35(5):1516-23. doi: 10.1111/liv.12597. Epub 2014 Jun 6.
10
The spread of multi drug resistant infections is leading to an increase in the empirical antibiotic treatment failure in cirrhosis: a prospective survey.多重耐药感染的传播导致肝硬化患者经验性抗生素治疗失败率上升:一项前瞻性调查。
PLoS One. 2015 May 21;10(5):e0127448. doi: 10.1371/journal.pone.0127448. eCollection 2015.

引用本文的文献

1
Clinical, Microbiological, and Antibiotic Treatment Characteristics of Bacterial Infections in Patients with Liver Cirrhosis in China: A Multicenter Study.中国肝硬化患者细菌感染的临床、微生物学及抗生素治疗特征:一项多中心研究
J Clin Transl Hepatol. 2025 Aug 28;13(8):644-654. doi: 10.14218/JCTH.2025.00211. Epub 2025 Jul 3.
2
Clinical impact of multidrug-resistant bacterial infections in patients with cirrhosis.肝硬化患者多重耐药菌感染的临床影响
Future Sci OA. 2024 May 14;10(1):FSO945. doi: 10.2144/fsoa-2023-0160. eCollection 2024.
3
Evaluation of the Prognostic Value of Existing Scoring Systems for Nosocomial Infection in Patients with Decompensated Liver Cirrhosis.
评价现有评分系统对失代偿期肝硬化患者医院感染预后的价值。
Turk J Gastroenterol. 2023 Jan;34(1):43-52. doi: 10.5152/tjg.2022.21547.
4
Infection deteriorating hepatitis B virus related acute-on-chronic liver failure: a retrospective cohort study.感染导致乙型肝炎病毒相关慢加急性肝衰竭病情恶化:一项回顾性队列研究。
BMC Gastroenterol. 2020 Sep 29;20(1):320. doi: 10.1186/s12876-020-01473-y.
5
Clinical risk factors and predictive tool of bacteremia in patients with cirrhosis.肝硬化患者菌血症的临床危险因素和预测工具。
J Int Med Res. 2020 May;48(5):300060520919220. doi: 10.1177/0300060520919220.